Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Endostatin, a collagen XVIII fragment, is a known inhibitor of angiogenesis.
• Fibroblast growth factor-2 (FGF-2) is a key inducer of angiogenesis.
• The role of endostatin's heparin-binding ability and intracellular signaling in its anti-angiogenic effects requires elucidation.

Purpose of the Study:

• To investigate the mechanism by which endostatin inhibits FGF-2-induced angiogenesis.
• To determine the role of endostatin's heparin-binding ability and Shb protein in endostatin's effects on endothelial cells.
• To explore endostatin's impact on endothelial cell cycle, morphogenesis, and apoptosis.

Main Methods:

• Utilized the chicken chorioallantoic membrane model to assess angiogenesis inhibition.
• Employed murine brain endothelial (IBE) cells, including those overexpressing Shb, to study cellular responses.
• Analyzed cell cycle progression, tubular morphogenesis in collagen gels, apoptosis, and protein tyrosine phosphorylation.

Main Results:

• Endostatin inhibited FGF-2-induced angiogenesis, an effect dependent on its heparin-binding ability.
• Endostatin induced apoptosis and altered tubular morphogenesis in IBE cells, particularly when Shb was overexpressed.
• Endostatin treatment led to tyrosine phosphorylation of Shb and the formation of multiprotein complexes involving a tyrosine kinase.

Conclusions:

• Endostatin's anti-angiogenic effects are mediated by inducing tyrosine kinase activity and apoptosis in endothelial cells.
• Heparin-binding ability of endostatin and Shb expression are critical for its pro-apoptotic and anti-angiogenic functions.
• Endostatin modulates endothelial cell behavior through intracellular signaling pathways involving tyrosine kinases.